Medtronic has initiated a new marketing campaign to promote its recently FDA-cleared diabetes management system, which integrates the MiniMed 780G insulin pump with Abbott’s Instinct glucose sensor. This strategic move aims to enhance user engagement and encourage individuals with Type 1 diabetes to take proactive control of their health.
The ‘Own It’ campaign reflects a growing trend in the medical device industry, where companies are increasingly focusing on patient empowerment and self-management solutions. By combining advanced technology with a motivational message, Medtronic seeks to position its product as not just a medical device but a vital tool for lifestyle management.
The implications for pharma professionals are significant; as patient-centric approaches gain traction, there is an increasing need for regulatory, QA/QC, and CMC teams to ensure that products not only meet safety and efficacy standards but also resonate with the end-users’ needs and preferences.
Start your 7-day trial and see what the database can do →
